Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TK1 | P04183 | 5/20 | 0.45 |
| ▸ | RNASE1 | P07998 | 1/20 | 0.44 |
| ▸ | TK2 | O00142 | 2/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL409820 | 0.91 | RNASE1 (0.50) | TK1RNASE1TK2 | |
| SCHEMBL441127 | 0.91 | RNASE1 (0.50) | TK1RNASE1TK2 | |
| SCHEMBL19953995 | 0.91 | TK1 (0.44) | TK1RNASE1TK2 | |
| SCHEMBL27157713 | 0.88 | TYMP (0.48) | TK1RNASE1TK2 | |
| SCHEMBL9978645 | 0.87 | TK1 (0.44) | TK1RNASE1TK2 | |
| SCHEMBL14968223 | 0.87 | TK1 (0.44) | TK1RNASE1TK2 | |
| SCHEMBL9978644 | 0.86 | TK1 (0.43) | TK1RNASE1TK2 | |
| SCHEMBL14968221 | 0.86 | TK1 (0.43) | TK1RNASE1TK2 | |
| SCHEMBL14967959 | 0.85 | TK1 (0.41) | TK1RNASE1TK2 | |
| SCHEMBL29975279 | 0.85 | TYMP (0.44) | TK1RNASE1TK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2017205880-A1 | PROCESSES FOR PREPARING PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS | SAREPTA THERAPEUTICS, INC. (US) | 2017-11-30 | — | — | WO | disclosed |
| WO-2017205496-A1 | PROCESSES FOR PREPARING OLIGOMERS | SAREPTA THERAPEUTICS, INC. (US) | 2017-11-30 | — | — | WO | disclosed |
| WO-2017205513-A1 | PROCESSES FOR PREPARING PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS | SAREPTA THERAPEUTICS, INC. (US) | 2017-11-30 | — | — | WO | disclosed |